Lamprene

Lamprene is a brand name of clofazimine, approved by the FDA in the following formulation(s):

LAMPRENE (clofazimine - capsule; oral)

• 
  Manufacturer: NOVARTIS
  
  Approval date: December 15, 1986
  
  Strength(s): 50MG ^[RLD]

Has a generic version of Lamprene been approved?

No. There is currently no therapeutically equivalent version of Lamprene available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lamprene. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Lamprene.

See also...

• Lamprene Advanced Consumer Information (Micromedex)
• Lamprene AHFS DI Monographs (ASHP)
• Clofazimine Advanced Consumer Information (Micromedex)
• Clofazimine AHFS DI Monographs (ASHP)